Authors:
VANBEEK ER
LOWIK CWGM
EBETINO FH
PAPAPOULOS SE
Citation: Er. Vanbeek et al., BINDING AND ANTIRESORPTIVE PROPERTIES OF HETEROCYCLE-CONTAINING BISPHOSPHONATE ANALOGS - STRUCTURE-ACTIVITY-RELATIONSHIPS, Bone (New York, N.Y.), 23(5), 1998, pp. 437-442
Citation: Rcm. Pelger et al., EFFECTS OF THE BISPHOSPHONATE OLPADRONATE IN PATIENTS WITH CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON, Bone, 22(4), 1998, pp. 403-408
Authors:
VANBEZOOIJEN RL
FARIHSIPS HCM
PAPAPOULOS SE
LOWIK CWGM
Citation: Rl. Vanbezooijen et al., IL-1-ALPHA, IL-1-BETA, IL-6, AND TNF-ALPHA STEADY-STATE MESSENGER-RNALEVELS ANALYZED BY REVERSE TRANSCRIPTION COMPETITIVE PCR IN BONE-MARROW OF GONADECTOMIZED MICE, Journal of bone and mineral research, 13(2), 1998, pp. 185-194
Authors:
BROWN RJ
VANBEEK E
WATTS DJ
LOWIK CWGM
PAPAPOULOS SE
Citation: Rj. Brown et al., DIFFERENTIAL-EFFECTS OF AMINOSUBSTITUTED ANALOGS OF HYDROXY BISPHOSPHONATES ON THE GROWTH OF DICTYOSTELIUM-DISCOIDEUM, Journal of bone and mineral research, 13(2), 1998, pp. 253-258
Authors:
VANBEZOOIJEN RL
QUE I
EDERVEEN AGH
KLOOSTERBOER HJ
PAPAPOULOS SE
LOWIK CWGM
Citation: Rl. Vanbezooijen et al., PLASMA NITRATE-STEROIDS BUT DO NOT CORRELATE WITH TRABECULAR BONE-MINERAL DENSITY IN RATS(NITRITE LEVELS ARE REGULATED BY OVARIAN), Journal of Endocrinology, 159(1), 1998, pp. 27-34
Citation: Er. Vanbeek et al., EFFECT OF ALENDRONATE TREATMENT ON THE OSTEOCLASTOGENIC POTENTIAL OF BONE-MARROW CELLS IN MICE, Bone, 20(4), 1997, pp. 335-340
Citation: Se. Papapoulos, PAGETS-DISEASE OF BONE - CLINICAL, PATHOGENETIC AND THERAPEUTIC ASPECTS, Bailliere's clinical endocrinology and metabolism, 11(1), 1997, pp. 117-143
Authors:
KARPERIEN M
FARIHSIPS H
HENDRIKS J
PAPAPOULOS SE
LANSKE B
ABOUSAMRA AB
LOWIK CWGM
DEFIZE LHK
Citation: M. Karperien et al., CHARACTERIZATION OF THE PTH PTHRP RECEPTOR GENE PROMOTER IN-VITRO ANDIN-VIVO - REGULATION BY RETINOIC ACID AND BMP2/, Journal of bone and mineral research, 12, 1997, pp. 122-122
Citation: Nat. Hamdy et al., EARLY LIFE-THREATENING HYPERCALCEMIA FOLLOWING SUCCESSFUL BONE-MARROWTRANSPLANTATION FOR INFANTILE MALIGNANT OSTEOPETROSIS, Journal of bone and mineral research, 12, 1997, pp. 528-528
Citation: Nat. Hamdy et al., WHERE BONE MEETS BONE-MARROW - STERNO-COSTOCLAVICULAR HYPEROSTOSIS - CLINICAL-FEATURES AND RESPONSE TO TREATMENT WITH BISPHOSPHONATES, Journal of bone and mineral research, 12, 1997, pp. 530-530
Authors:
LANDSMEERBEKER EA
MASSA GG
MAASWINKELMOOY PD
VANDEKAMP JJP
PAPAPOULOS SE
Citation: Ea. Landsmeerbeker et al., TREATMENT OF OSTEOGENESIS IMPERFECTA WITH THE BISPHOSPHONATE OLPADRONATE (DIMETHYLAMINOHYDROXYPROPYLIDENE BISPHOSPHONATE), European journal of pediatrics, 156(10), 1997, pp. 792-794
Citation: C. Brumsen et al., LONG-TERM EFFECTS OF BISPHOSPHONATES ON THE GROWING SKELETON - STUDIES OF YOUNG-PATIENTS WITH SEVERE OSTEOPOROSIS, Medicine, 76(4), 1997, pp. 266-283
Citation: Atm. Vanholtenverzantvoort et Se. Papapoulos, ORAL PAMIDRONATE IN THE PREVENTION AND TREATMENT OF SKELETAL METASTASES IN PATIENTS WITH BREAST-CANCER, Medicina, 57, 1997, pp. 109-113
Citation: Mg. Weissglas et al., THE ROLE OF INTERLEUKIN-6 IN THE INDUCTION OF HYPERCALCEMIA IN RENAL-CELL CARCINOMA TRANSPLANTED INTO NUDE-MICE, Endocrinology, 138(5), 1997, pp. 1879-1885
Authors:
VANHOLTENVERZANTVOORT ATM
HERMANS J
BEEX LVAM
BLIJHAM G
CLETON FJ
VANECKSMIT BCF
SLEEBOOM HP
PAPAPOULOS SE
Citation: Atm. Vanholtenverzantvoort et al., DOES SUPPORTIVE PAMIDRONATE TREATMENT PREVENT OR DELAY THE FIRST MANIFESTATION OF BONE METASTASES IN BREAST-CANCER PATIENTS, European journal of cancer, 32A(3), 1996, pp. 450-454
Authors:
HAMDY NAT
BRUMSEN C
WOLTHERS BG
PAPAPOULOS SE
Citation: Nat. Hamdy et al., URINARY HISTAMINE METABOLITES DETERMINATION IN THE SCREENING FOR MASTOCYTOSIS IN MALE-PATIENTS WITH OSTEOPOROSIS, Journal of bone and mineral research, 11, 1996, pp. 133-133
Authors:
BRUMSEN C
LANDMAN JO
KLUIN P
HAMDY NAT
PAPAPOULOS SE
Citation: C. Brumsen et al., SHOULD WE SCREEN FOR MASTOCYTOSIS IN PATIENTS WITH VERTEBRAL FRACTURES, Journal of bone and mineral research, 11, 1996, pp. 644-644
Authors:
PELGER RCM
LYCKLAMA GAB
NIJEHOLT A
ZWINDERMAN AH
PAPAPOULOS SE
HAMDY NAT
Citation: Rcm. Pelger et al., THE FLARE IN SERUM ALKALINE-PHOSPHATASE ACTIVITY AFTER ORCHIECTOMY - A VALUABLE NEGATIVE PROGNOSTIC INDEX FOR PROGRESSION-FREE SURVIVAL IN PROSTATIC-CARCINOMA, The Journal of urology, 156(1), 1996, pp. 122-126
Citation: Se. Papapoulos et M. Frolich, PREDICTION OF THE OUTCOME OF TREATMENT OF PAGETS-DISEASE OF BONE WITHBISPHOSPHONATES FROM SHORT-TERM CHANGES IN THE RATE OF BONE-RESORPTION, The Journal of clinical endocrinology and metabolism, 81(11), 1996, pp. 3993-3997
Authors:
VANDERPLUIJM G
VLOEDGRAVEN HJM
IVANOV B
ROBEY FA
GRZESIK WJ
ROBEY PG
PAPAPOULOS SE
LOWIK CWGM
Citation: G. Vanderpluijm et al., BONE SIALOPROTEIN PEPTIDES ARE POTENT INHIBITORS OF BREAST-CANCER CELL-ADHESION TO BONE, Cancer research, 56(8), 1996, pp. 1948-1955
Authors:
EGGELMEIJER F
PAPAPOULOS SE
VANPAASSEN HC
DIJKMANS BAC
VALKEMA R
WESTEDT ML
LANDMAN JO
PAUWELS EKJ
BREEDVELD FC
Citation: F. Eggelmeijer et al., INCREASED BONE MASS WITH PAMIDRONATE TREATMENT IN RHEUMATOID-ARTHRITIS - RESULTS OF A 3-YEAR RANDOMIZED, DOUBLE-BLIND TRIAL, Arthritis and rheumatism, 39(3), 1996, pp. 396-402
Citation: Jo. Landman et Se. Papapoulos, UNINTERRUPTED ORAL BISPHOSPHONATE (PAMIDRONATE) THERAPY OF PATIENTS WITH OSTEOPOROSIS IS NOT ASSOCIATED WITH CHRONIC STIMULATION OF PARATHYROID-HORMONE SECRETION, Osteoporosis international, 5(2), 1995, pp. 93-96